SCA Approves BOD Proposal to Distribute all Shares in Essity to Shareholders
Print this Article | Send to Colleague
On April 5, the Annual General Meeting of Svenska Cellulosa Aktiebolaget SCA (SCA) decided in favor of the Board of Director’s proposal to distribute all shares in Essity Aktiebolag (Essity) (formerly SCA Hygiene) to SCA’s shareholders. The Board of Director’s were at the same time authorized to determine the record date for the distribution. SCA’s Board of Director’s has now set the record date for the distribution at Tuesday, June 13, 2017.
All shares in the wholly owned subsidiary Essity will be distributed, according to which one share of Class A in SCA carries entitlement to one share of Class A in Essity and one share of Class B in SCA carries entitlement to one share of Class B in Essity. Aside from being registered as a shareholder of SCA on the record date for distribution, no further actions are required by shareholders in order to receive shares in Essity.
Nasdaq Stockholm’s Listing Committee has decided to admit Essity’s Class A shares and Class B shares for trading on Nasdaq Stockholm.
The last day for trading in the SCA share with the right to receive distribution of shares in Essity was Friday, June 9, 2017. As of Monday, June 12, 2017, the SCA share was traded without the right to receive distribution of shares in Essity.
For Essity the first day of trading is expected to be Thursday, June 15, 2017. Essity’s Class A shares will be traded under the ticker ESSITY A with the ISIN code SE0009922156 and Class B shares will be traded under the ticker ESSITY B with the ISIN code SE0009922164.
The prospectus for admission to trading of shares in Essity was expected to be published on June 7, 2017. The prospectus will be available on SCA’s www.sca.com) and Essity’s ( www.essity.com) websites.
SCA is a leading global hygiene and forest products company that sustainably develops, produces and sells personal care, tissue and forest products. Through the recently acquired company BSN medical, the Group offers products within wound care, compression therapy and orthopedics. Sales are conducted in approximately 150 countries under many strong brands, including the leading global brands TENA and Tork, and other brands, such as Leukoplast, Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. As Europe’s largest private forest owner, SCA places considerable emphasis on sustainable forest management. In 2016, the Group had approximately 46,000 employees and sales amounted to approximately SEK 117bn (EUR 12.4bn). SCA was founded in 1929, has its headquarters in Stockholm, Sweden, and is listed on Nasdaq Stockholm. SCA is dedicated to improving well-being through leading hygiene and health solutions. Back to Tissue360 Newsletter |
|
|